Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...

Background and objectives Peginterferon-α treatment exhibits low rates of the serological conversion rate of hepatitis B e ...

Peginterferon-α treatment exhibits low rates of the serological conversion rate of hepatitis B e antigen (HBeAg) and the negative conversion rate of ...

Scientists have developed a cancer vaccine that stopped three different types of aggressive tumors from growing in mice.

Google has announced a new AI model as part of a research collaboration with Yale University. If that sounds a little dry and ...

Explore a potential trade with CytomX (CTMX) stock as Q1’26 clinical data approaches for its EpCAM-targeting therapy. Read ...

An expert discusses how rilzabrutinib, a recently FDA-approved Bruton tyrosine kinase (BTK) inhibitor, targets the autoimmune pathophysiology of immune thrombocytopenia (ITP) by modulating B cells, ...

Objectives Patients with primary Sjögren’s disease (SjD) have an increased risk of B cell lymphoma. The aim of this study was ...

Researchers found that COVID-19 mRNA vaccines, when given within 100 days of starting immune checkpoint inhibitors, were ...

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly ...

An 82-year-old woman with a history of congestive heart failure was admitted to this hospital for volume overload. Ascites, ...